Cathy Eng, MD and Benjamin Weinberg, MD discuss the gut microbiome and how it impacts young patients with colorectal. They also discuss the potential to use gut microbiome test to inform diagnosis, treatment, and monitoring of patients.

Nagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.

Debra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States

In season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, associate professor. Clinical Research Division, Fred Hutchinson Cancer Research Center, spoke with fellow oncologist, Winston Tan, MD, medical oncologist and professor of medicine, Mayo Clinic, about the ever-changing treatment landscape for prostate cancer.

In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion with Stephanie Graff, MD, and Gabriel N. Hortobagyi, MD, FACP.

Sarah M. Temkin, MD leads a discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.

A discussion on immunotherapy use in non–small cell lung cancer between community physician Jason William, MD, DABR and research physician George R. Simon, MD, FACP, FCCP.